AB2 Bio and WuXi Biologics Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

NEXT STORY
ProMIS Neurosciences adds Dr. David Wishart to its Scientific Advisory Board
PREV STORY
Prefilled Syringes Market to Exhibit a CAGR of 10.5% and Hit USD 10.57 Billion by 2026; Amplified Production Capacities of Manufacturers During Coronavirus to Accelerate Sales, states Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Orion publishes Financial Statement Release for 2019 on 5 February 2020

author_avatar
NASDAQ Market News

iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with KEYTRUDA®

author_avatar
NASDAQ Market News

Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma

Helsinn Group announces agreement to acquire worldwide rights to Valchlor®/Ledaga® - an approved and marketed ...

author_avatar
NASDAQ Market News